Cormorant Capital

About The Fund

Cormorant Capital is an investment firm specializing in real estate, specifically catering to the growth of real estate operator and owner clients in the United States. Their expertise lies in co-investing in select transactions, where they provide capital alongside real estate operators to propel value-add strategies and more opportunistic projects. Such projects include upgrading units in existing multifamily buildings, as well as speculative industrial and self-storage development. Cormorant Capital is equipped to assist existing owners in search of new partners who bring operational or development expertise, especially in redevelopment scenarios. The firm is also involved in direct investments in real estate companies. A core tenet of Cormorant's strategy is ensuring alignment of interest between parties, which is seen as essential to the successful closing of any joint venture. They prize creative solutions in this process. Cormorant Capital is headquartered in New York, New York, and positions itself as a provider of strategic equity solutions for both new transactions and existing portfolios. Their advisory services reflect their extensive experience in sourcing and deploying capital. The firm's investment range is notably specific, with a minimum and maximum investment size of $70,000,000. Cormorant Capital's focus tends to align with life science and oncology industries, although the available descriptions emphasize their real estate activities.